Companies: 10,795·Total market cap: $144.5T
Avalon Acquisition Inc.

Avalon Acquisition Inc.

AVACUNASDAQFinancial Services
$8.90
$-1.99(-18.27%)
Market Cap$236874826
P/E Ratio
52W High$10.89
52W Low$10.86

Avalon Acquisition Inc. (AVACU) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

avacu · pe ratio · data through Dec 31, 2022

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Avalon Acquisition Inc. (AVACU) measures how much investors pay for each dollar of the company's trailing earnings. AVACU's current PE ratio of 28.85x is calculated by dividing its stock price of $8.90 by its TTM earnings per share of $0.32. +30.7% elevated vs 5Y avg 22.1x

28.85x
P/E Ratio (TTM)+30.7%

Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31

Forward P/E
N/A
EPS (TTM)
$0.32
TTM · diluted EPS
PEG Ratio
-0.00
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Avalon Acquisition Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2020 – 2022 · Annual
PE Ratio (TTM)
5Y Avg 22.1x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Shell Companies · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Avalon Acquisition Inc.
Avalon Acquisition Inc.You
AVACU
$237M28.85x+42.3%$0.32
Alpha Partners Technology Merger Corp.
Alpha Partners Technology Merger Corp.
APTM
$243MN/A-$31.14
BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc.
BBOT
$623MN/A-$4.30
Bluescape Opportunities Acquisition Corp.
Bluescape Opportunities Acquisition Corp.
BOAC
$226MN/A
B. Riley Principal 250 Merger Corp.
B. Riley Principal 250 Merger Corp.
BRIV
$226M32.69x+61.3%$0.30
Coeptis Therapeutics, Inc.
Coeptis Therapeutics, Inc.
COEP
$58MN/A-$2.81
Green Visor Financial Technology Acquisition Corp. I
Green Visor Financial Technology Acquisition Corp. I
GVCI
$265M7.85x-61.3%$1.32
Industry Average
2 peers with valid PE
20.27xbaseline

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 3 of 3 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2022-12-31Latest
FY2022
32.49x$0.32+178.7%
2021-12-31
FY2021
11.66x$0.85
2020-12-31
FY2020
$0.00

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Avalon Acquisition Inc. (AVACU) measures how much investors pay for each dollar of the company's trailing earnings. AVACU's current PE ratio of 28.85x is calculated by dividing its stock price of $8.90 by its TTM earnings per share of $0.32.

PE Ratio = Stock Price ÷ EPS (TTM)
= $8.90 ÷ $0.32 = 28.85x
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

AVACU pe ratio · 6 questions

AVACU's current PE ratio is 28.85x as of 2026-06-09, based on a stock price of $8.90 and TTM EPS of $0.32. Data sourced from Financial Modeling Prep via AVACU's SEC 10-K and 10-Q filings.

AVACU PE ratioWhat is AVACU PE ratioCurrent PE ratio of AVACUAVACU PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Avalon Acquisition Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09